Dr. Clifford Hudis: Adjuvant Therapy for Breast Cancer

OncologySTAT Advisory Board member Dr. Clifford Hudis recommends the following 2009 SABCS Annual Meeting abstracts for physicians who want the latest updates on adjuvant hormonal therapy and adjuvant chemotherapy for breast cancer. Dr. Hudis is Chief, Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center. For more information about Dr. Hudis, view his profile. ADJUVANT HORMONAL THERAPYAbstract 11Five Years of Exemestane as Initial Therapy Compared to 5 Years of Tamoxifen Followed...

NOT A MEMBER?

Registration is FREE

  • Up-to-date oncology news
  • Journal article summaries
  • Commentaries and interviews
  • Drug and interactions database
  • Chemotherapy regimens
  • Daily e-newsletters

 

Editors' Choice

Long-Term Posttransplant Bortezomib Boosts Outcome in Myeloma With del(17p13)

Cancer Type

  • Bladder
  • Bone
  • Breast
  • Breast (ER-Positive)
  • CNS/Brain
  • Colon and Rectum
  • Endocrine System
  • Esophagus
  • GYN (Non-Ovary)
  • GYN (Ovary)
  • Head and Neck
  • Hodgkin's Lymphoma
  • Kidney (Renal Cell)
  • Leukemia
  • Liver and Bile Duct
  • Lung
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Non-Hodgkin's Lymphoma
  • Pancreas
  • Pediatric Cancers
  • Prostate
  • Rare Cancers
  • Skin
  • Soft-Tissue Sarcoma
  • Stomach
  • Testicle
  • Forgot your password?
    Not a member? Free registration